The US Preventive Services Task Force an influential and often controversial panel of doctors is moving toward a recommendation for testing that could apply to all baby boomers The group issued   to doctors saying they should consider giving a   to people born between  and  regardless of their risk factors for having the disease Until now the group has recommended the test only for people at high risk for the infection such as those with a history of intravenous drug users or those who received a blood transfusion prior to  The panel   it may no longer be be a good idea for doctors to rely on patients to disclose their risk factors Someone who received a blood transfusion before  when routine screening of blood donations for hepatitis C started may not remember it more than  years later Also patients who used intravenous drugs  even once  in their youth may be reluctant to tell their doctors about it as an adult Threefourths of all people in the US with hepatitis C a viral infection are baby boomers   the Centers for Disease Control and Prevention Most have no idea theyre infected with the virus that causes the disease because people can be free of symptoms for decades before serious liver damage becomes apparent If the task force ends up adopting this draft recommendation it will follow one from the CDC   an even stronger hepatitis C recommendation earlier this year The CDC advised that all baby boomers get tested Hepatitis C infections are a leading cause of liver transplants But infections can be treated with a combination of drugs That   can last almost a year and cost as much as  though People without insurance who test positive for hepatitis C can get labeled with a preexisting condition that makes it difficult for them to get insurance at least until a ban on insurers rejecting people over preexisting conditions   Considerations regarding insurance coverage are real affecting individuals and their loved ones     director of the CDCs viral hepatitis division told   These issues are ones we must continue to consider as part of any implementation of these recommendations Ultimately though   has shown that treating hepatitis C infections is more costeffective than treating the diseases serious complications such as cirrhosis and liver cancer